AU2002238799A1 - Combination therapy for reduction of toxycity of chemotherapeutic agents - Google Patents

Combination therapy for reduction of toxycity of chemotherapeutic agents

Info

Publication number
AU2002238799A1
AU2002238799A1 AU2002238799A AU2002238799A AU2002238799A1 AU 2002238799 A1 AU2002238799 A1 AU 2002238799A1 AU 2002238799 A AU2002238799 A AU 2002238799A AU 2002238799 A AU2002238799 A AU 2002238799A AU 2002238799 A1 AU2002238799 A1 AU 2002238799A1
Authority
AU
Australia
Prior art keywords
toxycity
reduction
combination therapy
chemotherapeutic agents
chemotherapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002238799A
Inventor
Patrick T. Prendergast
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002238799A1 publication Critical patent/AU2002238799A1/en
Abandoned legal-status Critical Current

Links

AU2002238799A 2001-03-06 2002-03-05 Combination therapy for reduction of toxycity of chemotherapeutic agents Abandoned AU2002238799A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IES2001/0209 2001-03-06

Publications (1)

Publication Number Publication Date
AU2002238799A1 true AU2002238799A1 (en) 2002-09-19

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002322719A1 (en) Delivery of therapeutic capable agents
HK1208446A1 (en) Derivatives of uk-2a uk-2a
HK1075619A1 (en) New uses for anti-malarial therapeutic agents
AUPR738301A0 (en) Chemotherapeutic agents
AU2002257936A1 (en) Methods of well treatment
AU2002350235A1 (en) Combination bacteriolytic therapy for the treatment of tumors
AU2002252456A1 (en) Combination treatment of pancreatic cancer
AU2002353739A1 (en) Therapeutic compounds
AU2002240942A1 (en) Improved delivery of benefit agents
AU2002334891A1 (en) Tumor targeted photodiagnostic-phototherapeutic agents
AU2002335667A1 (en) Modified reoviral therapy
AU2002257411A1 (en) Individualization of therapy with antineoplastic agents
AU2002238799A1 (en) Combination therapy for reduction of toxycity of chemotherapeutic agents
AU2002257451A1 (en) Individualization of therapy with antibiotic agents
AU2002351382A1 (en) Combination cancer therapy
AU2002247127A1 (en) Therapy for cerebral vasospasm
AU2002304733A1 (en) Amino-aza-cyclohexanes for the treatment of malaria
AU2002354294A1 (en) Therapeutic agents for low HDL-cholesterolemia
AU2002319719A1 (en) Delivery of therapeutic capable agents
HU0104370D0 (en) Honeyed schnaps of oerseg
AUPR817901A0 (en) Therapeutic compounds
AUPR964001A0 (en) Therapeutic compounds
AUPR693801A0 (en) Therapeutic compounds
AU2002254030A1 (en) Treatment of schizophrenia
AU2002350507A1 (en) Use of cystathionine